Specific reversal of multidrug resistance to colchicine in CEM/VLB100 cells by Gynostemma pentaphyllum extract

Phytomedicine

Volumn 14, Issue 12, 2007, Pages 830-839

  Huang, T H W ^a   Bebawy, M ^a   Tran, V H ^a   Roufogalis, B D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Colchicine; Gynostemma pentaphyllum; Gypenoside; Multidrug resistance; P glycoprotein

Indexed keywords

COLCHICINE; GLYCOPROTEIN P; GYNOSTEMMA PENTAPHYLLUM EXTRACT; PACLITAXEL; PLANT EXTRACT; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CANCER RESISTANCE; CHANNEL GATING; CONTROLLED STUDY; DRUG ISOLATION; DRUG TRANSPORT; GENE OVEREXPRESSION; GYNOSTEMMA; GYNOSTEMMA PENTAPHYLLUM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CHROMATOGRAPHY, THIN LAYER; COLCHICINE; DRUG RESISTANCE, MULTIPLE; GYNOSTEMMA; HUMANS; PLANT EXTRACTS;

GYNOSTEMMA PENTAPHYLLUM;

EID: 35548945424     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.09.006     Document Type: Article

References (33)

1. Attawish A., Chivapat S., Phadungpat S., Bansiddhi J., Techadamrongsin Y., Mitrijit O., Chaorai B., and Chavalittumrong P. Chronic toxicity of Gynostemma pentaphyllum. Fitoterapia 75 (2004) 539-551
2. Ayesh S., Shao Y.M., and Stein W.D. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta 1316 (1996) 8-18
3. Barnes K.M., Dickstein B., Culter G.B., Fojo T., and Bates S.E. Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35 (1996) 4820-4827
4. Bebawy M., Morris M.B., and Roufogalis B.D. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles. Anal. Biochem. 268 (1999) 270-277
5. Bebawy M., Morris M.B., and Roufogalis B.D. Selective modulation of P-glycoprotein-mediated drug resistance. Br. J. Cancer 85 (2001) 1998-2003
6. Conseil G., Baubichon-Cortay H., Dayan G., Jault J.M., Barrens D., and Pietro A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Biochemistry 95 (1998) 9831-9836
7. Cui J.F., Eneroth P., and Bruhn J.G. Gynostemma pentaphyllum: identification of major sapogenins and differentiation from Panax species. Eur. J. Pharm. Sci. 8 (1999) 187-191
8. Di Pietro A., Dayan G., Conseil G., Steinfels E., Krell T., Trompier D., Baubichon-Cortay H., and Jault J. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships. Braz. J. Med. Biol. Res. 32 (1999) 925-939
9. Fardel O., Courtois A., Drenou B., Lamy T., Lecureur V., le Prise P.Y., and Fauchet R. Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone. Anticancer Drugs 7 (1996) 671-677
10. Ford J.M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur. J. Cancer 32 (1996) 991-1001
11. Gifford A.J., Kavallaris M., Madafiglio J., Matherly L.H., Stewart B.W., Haber M., and Norris M.D. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene. Int. J. Cancer 78 (1998) 176-181
12. Gottesman M.M., Pastan I., and Ambudkar S.V. P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Devel. 6 (1996) 610-617
13. Guo, W.Y., Wang, W.X., 1993. Cultivation and Utilisation of Gynostemma pentaphyllum. Publishing House of Electronics, Science and Technology University, pp. 1-261.
14. Hamilton K.O., Yazdanian M.A., and Audus K.L. Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. Int. J. Pharm. 228 (2001) 171-179
15. Hostettmann K., and Marston A. Saponins. In: Phillipson J.D. (Ed). Chemistry and Pharmacology of Natural Products (1995), Cambridge University Press, Cambridge
16. Imai Y., Tsukahara S., Asada S., and Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res. 64 (2004) 4346-4352
17. Jian Su New Medical College. The Dictionary of Chinese Medicine (Zhong Yao Da Ci Dian) (1986), Shanghai Science and Technology Press, Shanghai, China
18. Juliano R.L., and Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455 (1976) 152-162
19. Kim S.W., Kwon H.Y., Chi D.W., Shim J.H., Park J.D., Lee Y.H., Pyo S., and Rhee D.K. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem. Pharmacol. 65 (2003) 75-82
20. Kimura Y., Matsuo M., Takahashi K., Saeki T., Kioka N., Amachi T., and Ueda K. ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein. Curr. Drug Metab. 5 (2004) 1-10
21. Lewis D.A., and Hanson P.J. Anti-ulcer drugs of plant origin. Prog. Med. Chem. 28 (1991) 201-231
22. Mahadevan D., and List A.F. Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies. Blood 104 (2004) 1940-1951
23. Meibohm B., and Derendorf H. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Int. J. Clin. Pharmacol. Ther. 35 (1997) 401-413
24. Morris M.E., and Zhang S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci. 78 (2006) 2116-2130
25. Pajic M., Bebawy M., Hoskins J.M., Roufogalis B.D., and Rivory L.P. Effect of short-term morphine exposure on P-glycoprotein expression and activity in cancer cell lines. Oncol. Rep. 11 (2004) 1091-1095
26. Razmovski-Naumovski V., Duke R.K., Turner P., and Duke C.C. (20S)-2α,3β,12β-Trihydroxydammar-24-ene 20-O-β-D-glucopyranoside (Gynosaponin TN1) as the 2.5-methanol solvate. Acta Crystallogr. E 61 (2005) O1239-O1241
27. Stein W.D. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77 (1997) 545-590
28. Thomas H., and Coley H.M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 10 (2003) 159-165
29. Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Komano T., and Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267 (1992) 24248-24252
30. van Zanden J.J., Wortelboer H.M., Bijlsma S., Punta A., Ustab M., van Bladeren P.J., Rietjens I.M.C.M., and Cnubben N.H.P. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem. Pharmacol. 69 (2005) 699-708
31. Wolf D.C., and Horwitz S.B. P-glycoprotein transports corticosterone and is photoaffinity-labelled by the steroid. Int. J. Cancer 52 (1992) 141-146
32. Xie P.S., and Yan Y.Z. HPTLC fingerprint identification of commercial ginseng drugs - reinvestigation of HPTLC of ginsenosides. J. High Resol. Chromatogr. Chromatogr. Commun. 10 (1987) 607-613
33. Zhang S., Yang X., Coburn R.A., and Morris M.E. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem. Pharmacol. 70 (2005) 627-639